Short-chain fatty acids (SCFAs) play a key role in health and disease, as they regulate gut
homeostasis and their deficiency is involved in the pathogenesis of several disorders …

The gut and the liver are characterized by mutual interactions between both organs, the
microbiome, diet and other environmental factors. The sum of these interactions is …

Abstract Scope In 2009, the European Society of Clinical Microbiology and Infectious
Diseases (ESCMID) published the first treatment guidance document for Clostridioides …

Background Clostridioides difficile infection is an urgent antibiotic-associated health threat
with few treatment options. Microbiota restoration with faecal microbiota transplantation is an …

Background Faecal microbiota transplantation (FMT) is an emerging treatment modality, but
its current clinical use and organisation are unknown. We aimed to describe the clinical use …

Background: Microbiota-based treatments reduce the incidence of recurrent Clostridioides
difficile infections (rCDIs), but prospectively collected safety data needed to broaden patient …

BACKGROUND Irritable bowel syndrome (IBS) is the most prevalent gastrointestinal
disorder in developed countries and reduces patients' quality of life, hinders their ability to …

The intestinal microbiota is recognized to play a role in the defense against infection, but
conversely also acts as a reservoir for potentially pathogenic organisms. Disruption to the …

The present guideline is an update and extension of the ESPEN scientific guideline on
Clinical Nutrition in Inflammatory Bowel Disease published first in 2017. The guideline has …

Objective Whether fecal microbiota transplantation (FMT) in patients with irritable bowel
syndrome (IBS) is effective in improving outcomes remains controversial. We assessed the …